Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Semaglutide GLP-1, the active ingredient in Ozempic and Wegovy, and Tirzepatide in Mounjaro, are approved for different uses
It is particularly useful for patients with type II diabetes, prompting the body to release more insulin in order to reduce and control blood sugar levels
In addition, Semaglutide GLP-1 may have a direct effect on fat cells, promoting the breakdown of cells, particularly when used as part of a comprehensive weight loss program
Separate 10 mg vials are used when researchers want independent dose control or a different ratio
US$ 25.75
US$ 28.26
US$ 21.06
US$ 26.54
